#jpm23 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #jpm23, aggregated by home.social.
-
See one of the world's most prestigious awards, the #NobelPeacePrize, up close during #OPCW Open Day! 🏅 OPCW received the #NobelPrize in 2013 for its extensive efforts to eliminate #ChemicalWeapons.
🗓️ 24 September
📍 The Hague
➡️ Register: https://www.eventbrite.com/e/just-peace-open-day-2023-opcw-tickets-680792266997?aff=odcleoeventsincollection&keep_tld=1 -
📣 Registration is now open for #OPCW Open Day! Join us on 24 September to learn about the OPCW's work, take part in interactive activities, view expert presentations, and more! Details & register ➡️ https://www.eventbrite.com/e/just-peace-open-day-2023-opcw-tickets-680792266997?aff=odcleoeventsincollection&keep_tld=1
-
2023 is looking to be a breakout year for Lumen; even more non-dilutive funding, and 4 or more drugs in the clinic, all due to an integrated biologics design and manufacturing platform powered by electricity that economically outcompetes everything else by orders of magnitude.
---
RT @LumenBio
Jonathan D. Grinstein speaks with Brian @Finrow (Lumen, CEO) at #JPM23Read the full article below,
https://www.genengnews.com/industry-news/re…
https://twitter.com/LumenBio/status/1613985615640686593 -
Antibody design is hard! Dunbrack and Gray have been doing excellent work for years in Rosetta including CDR redesign in the lab. Biswas is raising an important set of questions here at #JPM23 about claims of de novo design that don’t seem supported by the redesign data published. https://mobile.twitter.com/surgebiswas/status/1613232556673224705
-
https://pca.st/episode/cf34236b-d896-4631-b169-e41e3807bf0a With the 2023 J.P. Morgan Healthcare Conference drawing to a close, we look back on the biggest news of the meeting, what it means for the year in #biotech ahead, and whether the industry's biggest annual gathering might finally have outgrown its host city. #jpm23
-
Vertex presentation is standing room only as its CEO highlights company's success with CF and is now discussing how close its sickle cell treatment is to market. #JPM23
-
Watching the Incyte presentation, which is focused on dermatology and I'm now reflecting on the interesting explosion we've seen in the past couple of years with new topical creams that have real advantages over the corticosteroids that have been the norm since what, like the 1960s? #JPM23
-
-
seeing lots of #JPM23 biotech guides and calendars. where's the best equivalent for digital health?